HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease

Movement Disorders

Volumn 18, Issue 3, 2003, Pages 337-340

  Onofrj, Marco ^a   Luciano, Ana Lisa ^a   Iacono, Diego ^a   Thomas, Astrid ^a   Stocchi, Fabrizio ^a   Papola, Franco ^b   Adorno, Domenico ^b   Di Mascio, Rocco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b CNR   (Italy)

Author keywords

Hallucinations; HLA; Parkinson's disease; RBD

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DNA; DOPAMINE RECEPTOR STIMULATING AGENT; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR2 ANTIGEN; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; QUETIAPINE;

AGED; ALLELE; ARTICLE; BEHAVIOR DISORDER; CATAPLEXY; CLINICAL ARTICLE; CONTROLLED STUDY; DYSKINESIA; ELECTROMYOGRAPHY; FEMALE; HALLUCINATION; HAPLOTYPE; HLA TYPING; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; NARCOLEPSY; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; POLYSOMNOGRAPHY; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC TEST; QUESTIONNAIRE; RATING SCALE; REM SLEEP; SCORING SYSTEM; SEROTYPING; SLEEP DISORDER; STATISTICAL ANALYSIS; THOUGHT DISORDER;

AGED; CARRIER PROTEINS; FEMALE; HALLUCINATIONS; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-DR2 ANTIGEN; HUMANS; MALE; MOLECULAR CHAPERONES; PARKINSON DISEASE; REM SLEEP BEHAVIOR DISORDER; SAMPLING STUDIES;

EID: 0037354443     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10409     Document Type: Article

References (22)

1. Ring HA, Serra-Mestres J. Neuropsychiatry of the basal ganglia. J Neurol Neurosurg Psychiatry 2002;72:12-21.
2. Fènelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors. Brain 2000;123:733-745.
3. Pappert EJ, Goetz CG, Niederman FG, Raman R, Leurgans S. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord 1999;14:117-121.
4. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996;46:388-393.
5. Comella CL, Nardine TM, Diederich NJ, Stebbins GT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 1998;51:526-529.
6. Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001;16:622-630.
7. Arnulf I, Bonnet AM, Damier P, Bejjani BP, Seilhean D, Derenne JP, Agid Y. Hallucinations, REM sleep, and Parkinson's disease. Neurology 2000;55:281-288.
8. Ulivelli M, Rossi S, Lombardi C, Bartalini S, Rocchi R, Giannini F, Passero S, Battistini N, Lugaresi E. Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Neurology 2002;58:462-465.
9. Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001;18:78-105.
10. Langdon N, Welch KI, an Dam M, Vaugham R, Parkes K. Genetic markers in narcolepsy. Lancet 1984;2:1178.
11. Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, Okun M, Hohjoh H, Miki T, Hsu S, Leffell M, Grumet F, Fernandez-Vina M, Honda M, Risch N. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic group. Am J Hum Genet 2001;68:686-699.
12. Bentivoglio AR, Cortelli P, Valente EM, Ialongo T, Ferraris A, Elia A, Montagna P, Albanese A. Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families. Mov Disord 2001;16:999-1006.
13. World Medical Association- Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925-926.
14. Diederich N, Comella C. Sleep behavior disorder in Parkinsonism: diagnosis by interview-care giver. Sixth International Congress of Parkinson's Disease and Movement Disorders, Barcellona, Spain, June 11-15. Mov Disord 2000;15(Suppl.):185.
15. Diagnostic Classification Steering Committee, Thorpy MJ, Chairman. REM sleep behaviour disorder. In: International classification of sleep disorders: diagnostic coding manual. Rochester, MN: American Sleep Disorders Association; 1990. p 177-180.
16. Onofrj M, Curatola L, Ferracci F, Fulgente T. Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject. J Neurol Neurosurg Psychiatry 1992;55:852-853.
17. Mahowald MW, Schenk CH. REM sleep behaviour disorder. In: Kryger MH, Roth T, Dement WC, editors. Principles and practise of sleep medicine. Philadelphia: WB Saunders; 1989. p 389-401.
18. Baker TL, Guilleminault C, Nino-Murcia G, Dement WC. Comparative polysomnographic study of narcolepsy and idiopathic central nevous system hypersomnia. Sleep 1986;9:232-242.
19. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
20. Hawkins BR. Table of critical Chi-square values for investigations involving multiple comparisons. Tissue Antigens 1981;17:243-244.
21. Schlessman JJ. Case control studies: design, conduct, analysis. Oxford: Oxford University Press; 1981.
22. Rogers AE, Meehan J, Guilleminault C, Grumet FC, Mignot E. HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology 1997;48:1550-1556.